Mr Matthew Liew has been a consultant urologist in Wigan since 2017. He has sub-speciality interests in urinary stone disease treatment, bladder cancer, prostate cancer diagnostics and HoLEP (holmium laser enucleation of prostate). Matthew was Clinical Director during his first year as consultant and holds 3 Clinical Excellence Awards (CEAs). Matthew prides himself in developing patient pathways to optimise patient experience and outcomes.
Mr Matthew Liew is a keen innovator and performs HoLEP surgery, which many consider to be the gold standard surgical approach to treating prostate enlargement symptoms. The benefits compared to conventional prostate treatments (such as transurethral resection of prostate or TURP) are reduced bleeding/ short hospital stay, enhanced removal of prostate obstruction, with long- lasting benefits. He is currently the only HoLEP surgeon in Greater Manchester (GM), Lancashire and Yorkshire. Matthew has been an invited speaker on HoLEP, and chaired a BAUS (British Association of Urological Surgeons) session on BPH/LUTS.
Mr Matthew Liew is the first UK surgeon to carry out male circumcision using the latest generation novel CircCurerTM device. Matthew has mentored several urologists on this technique and presented his findings nationally, which include rapid surgery (under 10 mins), suitability for local anaesthesia, low post-operative pain, and 100% patient cosmetic satisfaction.
Mr Matthew Liew performs laser bladder tumour ablation (TULA) under local anaesthetic to avoid the need for a formal anaesthetic to treat small bladder tumour recurrences, and optimise patient experience outcomes. Matthew is the co-lead of the GM TULA service set up to support delivery of this service to every local trust. He also offers other new techniques including en-bloc bladder tumour resections (ERBT). Matthew is a named contributor to the 2022 Getting it Right First Time (GIRFT) urology guidance for Bladder Cancer.
Mr Matthew Liew developed the stone multidisciplinary team (MDT) in Wigan, Bolton and Salford and is a Key Opinion Leader in Endourology for Richard Wolf, Teleflex and Coloplast.
Mr Matthew Liew is an active researcher, with over 25 publications on a number of topics including prostate cancer, kidney stone disease and education. He is Principal Investigator in a number of key international trials. During 2021, he was Chief Investigator the only non-cancer urology trial in the UK. He received his research doctorate (Doctor of Medicine, MD) from the University of Manchester after an intensive study of Kidney Cancer chemotherapy resistance mechanisms at the Christie Hospital.
Mr Matthew Liew is an associate member of the European Association of Urologists Guidelines Panel for Prostate Cancer. These guidelines are the most sited urology guidance worldwide. Matthew also regularly reviews articles for BJUI (British Journal of Urology International).
Mr Matthew Liew is an accredited Royal College of Surgeons Educational Supervisor. Matthew has chaired numerous training sessions including the North West Annual Stone Course, as well as regional training sessions. He is faculty for the award winning Urology Bootcamp, and Course Director for the first NW BPH Simulation Masterclass. He is also involved in Antibiotic Stewardship and is an active member within his NHS trust.
Kidney/ Ureteric and Bladder stones
Minimally invasive stone surgery
Percutaneous Nephrolithotomy (PCNL)
Haematuria (blood in the urine)
Benign prostate diseases
HoLEP and Thullium Fibre laser enucleation of prostate
Lower urinary tract symptoms (LUTS)
Urinary tract infection
Penis / foreskin problems
Lumps / pain in the scrotum
Bladder cancer treatments: Mitomycin C instillations, En-bloc tumour resections and TULA (transurethral laser ablation)
Matthew enjoys spending time with his wife and daughters. He is a keen amateur footballer and musician. Matthew plays the violin, piano, drums and guitar regularly in his bands: Clutton Sounds (a urology rock band) and Stringbox (a Manchester based folk band). His latest band is more funk/ soul inspired creating original songs.